Methemoglobinemia risk factors: Difference between revisions
Tags: mobile edit mobile web edit |
Tags: mobile edit mobile web edit |
||
Line 28: | Line 28: | ||
There are three main congenital conditions that lead to methemoglobinemia: | There are three main congenital conditions that lead to methemoglobinemia: | ||
1. Cytochrome b5 reductase deficiency and pyruvate kinase deficiency | 1. [[Cytochrome b5 reductase deficiency]] and [[pyruvate kinase deficiency]] | ||
2. [[G6PD deficiency]] | 2. [[G6PD deficiency]] | ||
3. Presence of abnormal hemoglobin (Hb M) | 3. Presence of abnormal hemoglobin ([[Hb M]]) | ||
Both cytochrome b5 reductase deficiency and pyruvate kinase deficiency can lead to NADH deficiency which in turn will lead to decreased ability to remove MetHb from the blood. Cytochrome b5 reductase deficiency is an autosomal recessive disorder with at least 2 forms that we know of. | Both [[cytochrome b5 reductase deficiency]] and [[pyruvate kinase deficiency]] can lead to [[NADH deficiency]] which in turn will lead to decreased ability to remove MetHb from the blood. [[Cytochrome b5 reductase deficiency]] is an [[autosomal recessive disorder]] with at least 2 forms that we know of. | ||
The most common form, is the Ib5R deficiency, where cyt b5 reductase is absent only in RBCs, and the levels of MetHb are around 10% to 35%. | The most common form, is the [[Ib5R deficiency]], where [[cyt b5 reductase]] is absent only in [[RBCs]], and the levels of [[MetHb]] are around 10% to 35%. | ||
The second type, which is much less common, is the IIb5R, where MetHb varies between 10% and 15% and the cyt | The second type, which is much less common, is the [[IIb5R]], where [[MetHb]] varies between 10% and 15% and the [[cyt | ||
b5 reductase is absent in all cells. This form is associated with mental retardation, microcephaly, and other neurologic problems. The lifespan of the affected individuals is greatly affected and patients usually die very young. | b5 reductase]] is absent in all cells. This form is associated with mental retardation, [[microcephaly]], and other neurologic problems. The lifespan of the affected individuals is greatly affected and patients usually die very young. | ||
Congenital deficiency in G6PD can lead to decreased levels of NADPH and thus compromising the function of the diaphorase II enzyme system. | [[Congenital]] deficiency in [[G6PD]] can lead to decreased levels of [[NADPH]] and thus compromising the function of the [[diaphorase II enzyme]] system. | ||
Abnormal hemoglobins like Hb M, including Hb Ms, Hb MIwate, Hb MBoston, Hb MHyde Park, and Hb MSaskatoon, an autosomal dominant condition, can also lead to methemoglobinemia. In case of amino acid substitution in the alpha-chain of hemoglobin, we observe | Abnormal hemoglobins like [[Hb M]], including [[Hb Ms]], [[Hb MIwate]], [[Hb MBoston]], [[Hb MHyde Park]], and [[Hb MSaskatoon]], an autosomal dominant condition, can also lead to [[methemoglobinemia]]. In case of [[amino acid]] substitution in the alpha-chain of [[hemoglobin]], we observe [[cyanosi]]s at birth, and infants with beta chain amino acid substitution will present with [[cyanosis]] later around 4-6 months of age. | ||
'''Acquired methemoglobinemia''' | '''Acquired methemoglobinemia''' | ||
The acquired methemoglobinemia is significantly more common than the congenital one. It is associated with exposure to or ingestion of oxidant drugs, toxins or chemicals, that cause acute increment in methemoglobin levels, by overwhelming the normal physiologic protective enzyme mechanisms. The most common agents are anesthetics like [[benzocaine]], [[lidocaine]], [[prilocaine]], used locally or topically, antibiotics like [[dapsone]] (used for the treatment of [[Brown Recluse spider]] bites, [[Leprosy]], [[PCP]] prophylaxis, ecc) [[trimethoprim]], [[sulfonamides]], [[nitrates]]([[amynitrate])), [[nitroglycerin]] ([[NG]]), [[aniline dyes)], [[metoclopramide]], [[chlorates]] and [[bromates]]. | The acquired methemoglobinemia is significantly more common than the congenital one. It is associated with exposure to or ingestion of [[oxidant drugs]], toxins or chemicals, that cause acute increment in [[methemoglobin]] levels, by overwhelming the normal physiologic protective [[enzyme]] mechanisms. The most common agents are [[anesthetics]] like [[benzocaine]], [[lidocaine]], [[prilocaine]], used locally or topically, [[antibiotics]] like [[dapsone]] (used for the treatment of [[Brown Recluse spider]] bites, [[Leprosy]], [[PCP]] prophylaxis, ecc) [[trimethoprim]], [[sulfonamides]], [[nitrates]]([[amynitrate])), [[nitroglycerin]] ([[NG]]), [[aniline dyes)], [[metoclopramide]], [[chlorates]] and [[bromates]]. | ||
'''Drug Induced''' | '''Drug Induced''' | ||
• Anesthetics like [[benzocaine]], [[lidocaine]], [[prilocaine ]] | • [[Anesthetics]] like [[benzocaine]], [[lidocaine]], [[prilocaine ]] | ||
• [[Methylene blue]] | • [[Methylene blue]] | ||
Line 62: | Line 62: | ||
• [[Nitroglycerin]] | • [[Nitroglycerin]] | ||
• Antimalarial drugs like [[Primaquine phosphate]] (in nicotinamide adenine dinucleotide (NADH) methemoglobin reductase deficient individuals) | • Antimalarial drugs like [[Primaquine phosphate]] (in [[nicotinamide adenine dinucleotide]] ([[NADH]]) methemoglobin reductase deficient individuals) | ||
• [[Rasburicase]] | • [[Rasburicase]] | ||
Line 83: | Line 83: | ||
'''Contaminated well water''' (in premature infants and infants younger than 4 months) | '''Contaminated well water''' (in premature infants and infants younger than 4 months) | ||
'''Solid foods''' (not well cooked vegetables high in nitrates in premature infants and infants younger than 4 months) | '''Solid foods''' (not well cooked vegetables high in [[nitrates]] in premature infants and infants younger than 4 months) | ||
==References== | ==References== |
Revision as of 16:06, 14 May 2018
Methemoglobinemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Methemoglobinemia risk factors On the Web |
American Roentgen Ray Society Images of Methemoglobinemia risk factors |
Risk calculators and risk factors for Methemoglobinemia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Template:Aksiniya K. Stevasarova, M.D.
Overview
Congenital (Hereditary) Methemoglobinemia
There are three main congenital conditions that lead to methemoglobinemia:
1. Cytochrome b5 reductase deficiency and pyruvate kinase deficiency
3. Presence of abnormal hemoglobin (Hb M)
Acquired or Acute Methemoglobinemia
Some of the most common causes include different oxidant drugs, toxins and chemicals
Risk Factors
Congenital (Hereditary) Methemoglobinemia
There are three main congenital conditions that lead to methemoglobinemia:
1. Cytochrome b5 reductase deficiency and pyruvate kinase deficiency
3. Presence of abnormal hemoglobin (Hb M)
Both cytochrome b5 reductase deficiency and pyruvate kinase deficiency can lead to NADH deficiency which in turn will lead to decreased ability to remove MetHb from the blood. Cytochrome b5 reductase deficiency is an autosomal recessive disorder with at least 2 forms that we know of.
The most common form, is the Ib5R deficiency, where cyt b5 reductase is absent only in RBCs, and the levels of MetHb are around 10% to 35%.
The second type, which is much less common, is the IIb5R, where MetHb varies between 10% and 15% and the [[cyt b5 reductase]] is absent in all cells. This form is associated with mental retardation, microcephaly, and other neurologic problems. The lifespan of the affected individuals is greatly affected and patients usually die very young.
Congenital deficiency in G6PD can lead to decreased levels of NADPH and thus compromising the function of the diaphorase II enzyme system.
Abnormal hemoglobins like Hb M, including Hb Ms, Hb MIwate, Hb MBoston, Hb MHyde Park, and Hb MSaskatoon, an autosomal dominant condition, can also lead to methemoglobinemia. In case of amino acid substitution in the alpha-chain of hemoglobin, we observe cyanosis at birth, and infants with beta chain amino acid substitution will present with cyanosis later around 4-6 months of age.
Acquired methemoglobinemia
The acquired methemoglobinemia is significantly more common than the congenital one. It is associated with exposure to or ingestion of oxidant drugs, toxins or chemicals, that cause acute increment in methemoglobin levels, by overwhelming the normal physiologic protective enzyme mechanisms. The most common agents are anesthetics like benzocaine, lidocaine, prilocaine, used locally or topically, antibiotics like dapsone (used for the treatment of Brown Recluse spider bites, Leprosy, PCP prophylaxis, ecc) trimethoprim, sulfonamides, nitrates([[amynitrate])), nitroglycerin (NG), [[aniline dyes)], metoclopramide, chlorates and bromates.
Drug Induced
• Anesthetics like benzocaine, lidocaine, prilocaine
• Antimalarial drugs like Primaquine phosphate (in nicotinamide adenine dinucleotide (NADH) methemoglobin reductase deficient individuals)
• Dapsone
• Chlorates and Bromates and others
Contaminated well water (in premature infants and infants younger than 4 months)
Solid foods (not well cooked vegetables high in nitrates in premature infants and infants younger than 4 months)
References
- ↑ Template:Med Toxicol. 1986 Jul-Aug;1(4):253-60. Drug- and chemical-induced methaemoglobinaemia. Clinical features and management. Hall AH, Kulig KW, Rumack BH.pmid=PMID: 3537620
- ↑ {{Rev Bras Anestesiol. 2008 Nov-Dec;58(6):651-64. Methemoglobinemia: from diagnosis to treatment. [Article in English, Portuguese] do Nascimento TS1, Pereira RO, de Mello HL, Costa J. pmid=19082413}}